Computational methods in drug discovery. Sliwoski G, Kothiwale S, Meiler J, Lowe EW (2014) Pharmacol Rev 66: 334-95 Recent Structural Insights into Cytochrome P450 Function. Guengerich FP, Waterman MR, Egli M (2016) Trends Pharmacol Sci 37: 625-640 Drug dosing consideration in patients with acute and chronic kidney disease-a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). Matzke GR, Aronoff GR, Atkinson AJ, Bennett WM, Decker BS, Eckardt KU, Golper T, Grabe DW, Kasiske B, Keller F, Kielstein JT, Mehta R, Mueller BA, Pasko DA, Schaefer F, Sica DA, Inker LA, Umans JG, Murray P (2011) Kidney Int 80: 1122-37 Transporters and drug therapy: implications for drug disposition and disease. Ho RH, Kim RB (2005) Clin Pharmacol Ther 78: 260-77 "Inactive" excipients such as Cremophor can affect in vivo drug disposition. Wandel C, Kim RB, Stein CM (2003) Clin Pharmacol Ther 73: 394-6 Are herbal products dietary supplements or drugs? An important question for public safety. Stein CM (2002) Clin Pharmacol Ther 71: 411-3 Pharmacokinetic assessment in patients receiving continuous RRT: perspectives from the Kidney Health Initiative. Nolin TD, Aronoff GR, Fissell WH, Jain L, Madabushi R, Reynolds K, Zhang L, Huang SM, Mehrotra R, Flessner MF, Leypoldt JK, Witcher JW, Zineh I, Archdeacon P, Roy-Chaudhury P, Goldstein SL, Kidney Health Initiative (2015) Clin J Am Soc Nephrol 10: 159-64 Interrelationship between substrates and inhibitors of human CYP3A and P-glycoprotein. Kim RB, Wandel C, Leake B, Cvetkovic M, Fromm MF, Dempsey PJ, Roden MM, Belas F, Chaudhary AK, Roden DM, Wood AJ, Wilkinson GR (1999) Pharm Res 16: 408-14 Update information on drug metabolism systems--2009, part II: summary of information on the effects of diseases and environmental factors on human cytochrome P450 (CYP) enzymes and transporters. Rendic S, Guengerich FP (2010) Curr Drug Metab 11: 4-84 Introduction: use of radioactive compounds in drug discovery and development. Guengerich FP (2012) Chem Res Toxicol 25: 511-2 Genome-wide association studies in pharmacogenomics: successes and lessons. Motsinger-Reif AA, Jorgenson E, Relling MV, Kroetz DL, Weinshilboum R, Cox NJ, Roden DM (2013) Pharmacogenet Genomics 23: 383-94 Machine learning-based prediction of drug-drug interactions by integrating drug phenotypic, therapeutic, chemical, and genomic properties. Cheng F, Zhao Z (2014) J Am Med Inform Assoc 21: e278-86 Synthesis and stereochemical effects of pyrrolidinyl-acetylenic thieno[3,2-d]pyrimidines as EGFR and ErbB-2 inhibitors. Stevens KL, Alligood KJ, Alberti JG, Caferro TR, Chamberlain SD, Dickerson SH, Dickson HD, Emerson HK, Griffin RJ, Hubbard RD, Keith BR, Mullin RJ, Petrov KG, Gerding RM, Reno MJ, Rheault TR, Rusnak DW, Sammond DM, Smith SC, Uehling DE, Waterson AG, Wood ER (2009) Bioorg Med Chem Lett 19: 21-6 The role of convection during simulated continuous arteriovenous hemodialysis. Golper TA, Cigarran-Guldris S, Jenkins RD, Brier ME (1991) Contrib Nephrol 93: 146-8 Drug removal during continuous hemofiltration or hemodialysis. Golper TA (1991) Contrib Nephrol 93: 110-6
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.